AstraZeneca
AZN
#70
Rank
NZ$439.48 B
Marketcap
NZ$283.37
Share price
-0.84%
Change (1 day)
-5.27%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$11.48

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$11.92. In 2024 the company made an earnings per share (EPS) of NZ$8.10 an increase over its 2023 EPS that were of NZ$6.85.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.48
2024NZ$8.1018.23%
2023NZ$6.8581.13%
2022NZ$3.78631.03%
2021NZ$0.52-88.11%
2020NZ$4.35136.89%
2019NZ$1.84-39.41%
2018NZ$3.03-28.27%
2017NZ$4.23-14.37%
2016NZ$4.9424.11%
2015NZ$3.98127.55%
2014NZ$1.75-51.96%
2013NZ$3.64-58.95%
2012NZ$8.87-32.2%
2011NZ$13.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.59 30.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.89-0.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.56-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.33 347.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.40-71.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$10.14-14.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.26-81.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.10-32.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.71-52.13%๐Ÿ‡ฌ๐Ÿ‡ง UK